title: Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies.
authors.affiliation: Division of Hematology/Oncology, Cornell University Medical College, New York, NY 10021, USA. rsimant@mail.cornell.med.edu
authors.forename: R
authors.initials: R
authors.lastname: Simantov
authors.forename: S K
authors.initials: SK
authors.lastname: Lo
authors.forename: J E
authors.initials: JE
authors.lastname: Salmon
authors.forename: L R
authors.initials: LR
authors.lastname: Sammaritano
authors.forename: R L
authors.initials: RL
authors.lastname: Silverstein
mesh_terms: D017152:Antibodies, Antiphospholipid / Q000032:analysis*; D015415:Biomarkers; D005165:Factor V / Q000032:analysis* / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000235:genetics; D013927:Thrombosis / Q000097:blood* / Q000235:genetics
chemical_list: D017152:Antibodies, Antiphospholipid; D015415:Biomarkers; C095381:factor V Leiden; D005165:Factor V